Marvyn T. Koning

691 citations
23 papers · 295 indexed · h-index 8
Topics
T-cell and B-cell Immunology (6 papers)Monoclonal and Polyclonal Antibodies Research (6 papers)Lymphoma Diagnosis and Treatment (6 papers)
Journals
The Journal of Experimental MedicineSHILAP Revista de lepidopterologíaBlood
Partner nations
NetherlandsChileGermany

In The Last Decade

Marvyn T. Koning

21 papers receiving 289 citations

Peers

Marvyn T. Koning
Comparison fields: 5 of 52
  • Pathology and Forensic Medicine 134
  • Surgery 116
  • Radiology, Nuclear Medicine and Imaging 65
  • Neurology 62
  • Molecular Biology 59
Replace Ayataka Ishikawa with:
Ayataka Ishikawa Japan
Jean‐Baptiste Vulsteke Belgium
Simeon A. Lauer United States
Kayo Kunimoto Japan
Samuel Rosner United States
William J. Meecham United States
Larissa A. Habib United States
Sharath C. Raja United States
Koichi Shimizu Japan
Carine Delbrouck Belgium
Marvyn T. Koning relative to Ayataka Ishikawa Japan Ayataka Ishikawa's profile →
Citations per field
00.5×4.3×
Ayataka Ishikawa · 1×
Citations per year

Countries citing papers authored by Marvyn T. Koning

Since Specialization
Citations

This map shows the geographic impact of Marvyn T. Koning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marvyn T. Koning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marvyn T. Koning more than expected).

Fields of papers citing papers by Marvyn T. Koning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marvyn T. Koning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marvyn T. Koning. The network helps show where Marvyn T. Koning may publish in the future.

Co-authorship network of co-authors of Marvyn T. Koning

This figure shows the co-authorship network connecting the top 25 collaborators of Marvyn T. Koning. A scholar is included among the top collaborators of Marvyn T. Koning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marvyn T. Koning. Marvyn T. Koning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 5
4 3
5 2
6 1
7 1
8 30
9 68
10
MuSK myasthenia gravis monoclonal antibodies
1
11 12
12 28
13 10
14 12
15 1
16 26
17 87
18 1
19 0
20 1

About Marvyn T. Koning

Marvyn T. Koning is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology, having authored 23 papers that have together received 295 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Lymphoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (134 citations), Neurology (62 citations) and Radiology, Nuclear Medicine and Imaging (65 citations). Marvyn T. Koning has collaborated with scholars based in Netherlands, Chile and Germany. Frequent co-authors include Carmen Vleggeert‐Lankamp, Iris Noordhoek, Wilco Jacobs, Hendrik Veelken, Linda M. Slot, René E. M. Toes, Hans Ulrich Scherer, Inge E. van Es, Silvère M. van der Maarel and Jan J.G.M. Verschuuren. Their work appears in journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026